Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis

Ie-Ming Shih1, Li Chen, Chen C Wang

  • 1Division of Gynecologic Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. ishih@jhmi.edu

Abstract

Insights

DNA methylation profiles differ across ovarian serous neoplasms. High-grade serous carcinomas show fewer hypermethylated genes than low-grade types, suggesting distinct biological pathways.

Area of Science:

  • Oncology
  • Epigenetics
  • Gynecologic Pathology

Background:

  • Ovarian serous neoplasms represent a spectrum of tumors with varying grades of malignancy.
  • Understanding the molecular underpinnings, particularly epigenetic alterations like DNA methylation, is crucial for accurate classification and diagnosis.

Purpose of the Study:

  • To investigate and compare DNA methylation profiles across various types of ovarian serous neoplasms.
  • To identify potential epigenetic distinctions between benign, borderline, and malignant serous tumors.

Main Methods:

  • Utilized Illumina bead array technology for DNA methylation profiling.
  • Analyzed DNA methylation in enriched tumor cells from 75 benign and malignant serous tumor tissues.
  • Included 6 tumor-associated stromal cell cultures in the analysis.

Main Results:

  • High-grade serous carcinomas exhibited significantly fewer hypermethylated genes compared to low-grade serous carcinoma and borderline tumors.
  • Serous cystadenomas had the highest number of hypermethylated genes.
  • Unsupervised analysis revealed distinct clustering: serous cystadenoma, serous borderline tumor, and low-grade serous carcinomas grouped together, separate from high-grade serous carcinomas.

Conclusions:

  • Low-grade and high-grade serous carcinomas represent distinct entities at the molecular level.
  • Low-grade serous carcinomas share epigenetic similarities with serous borderline tumors and cystadenomas, suggesting a potential developmental or etiological link.
  • High-grade serous carcinomas appear epigenetically divergent from lower-grade counterparts and benign/borderline lesions.